Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Pawlotsky

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Gastroenterology|April 16, 2016
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free RegimensJean-Michel Pawlotsky
Cold Spring Harbor Perspectives in Medicine|January 23, 2020
Interferon-Free Hepatitis C Virus TherapyJean-Michel Pawlotsky
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Hepatitis C virus: standard-of-care treatmentJean-Michel Pawlotsky
F1000 Biology Reports|March 10, 2012
New antiviral agents for hepatitis CJean-Michel Pawlotsky
Seminars in Liver Disease|February 26, 2005
Current and future concepts in hepatitis C therapyJean-Michel Pawlotsky
Current Topics in Microbiology and Immunology|March 7, 2013
Treatment of chronic hepatitis C: current and futureJean-Michel Pawlotsky
Current Gastroenterology Reports|January 15, 2013
Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?Jean-Michel Pawlotsky
Gastroenterology|March 18, 2014
New hepatitis C therapies: the toolbox, strategies, and challengesJean-Michel Pawlotsky
Clinics in Liver Disease|April 15, 2003
Use and interpretation of hepatitis C virus diagnostic assaysJean-Michel Pawlotsky
Hepatology (Baltimore, Md.)|March 5, 2011
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virusJean-Michel Pawlotsky
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Gastroenterology|April 16, 2016
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free RegimensJean-Michel Pawlotsky
Cold Spring Harbor Perspectives in Medicine|January 23, 2020
Interferon-Free Hepatitis C Virus TherapyJean-Michel Pawlotsky
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Hepatitis C virus: standard-of-care treatmentJean-Michel Pawlotsky
F1000 Biology Reports|March 10, 2012
New antiviral agents for hepatitis CJean-Michel Pawlotsky
Seminars in Liver Disease|February 26, 2005
Current and future concepts in hepatitis C therapyJean-Michel Pawlotsky
Current Topics in Microbiology and Immunology|March 7, 2013
Treatment of chronic hepatitis C: current and futureJean-Michel Pawlotsky
Current Gastroenterology Reports|January 15, 2013
Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?Jean-Michel Pawlotsky
Gastroenterology|March 18, 2014
New hepatitis C therapies: the toolbox, strategies, and challengesJean-Michel Pawlotsky
Clinics in Liver Disease|April 15, 2003
Use and interpretation of hepatitis C virus diagnostic assaysJean-Michel Pawlotsky
Hepatology (Baltimore, Md.)|March 5, 2011
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virusJean-Michel Pawlotsky
Pageof 30